Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Naomi Kawashima, M.D., Ph.D.

Concepts (147)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute11202436021.650 Why?
fms-Like Tyrosine Kinase 3420244951.000 Why?
Core Binding Factor Alpha 2 Subunit320243510.730 Why?
Hematopoietic Stem Cell Transplantation8202156490.720 Why?
DNA Repeat Expansion12020720.690 Why?
Chromosomes, Human, Pair 21120182280.610 Why?
Chromosomes, Human, Pair 8120184520.550 Why?
Donor Selection120182280.520 Why?
Gene Expression Regulation, Leukemic120186460.490 Why?
Oncogene Proteins, Fusion2201815960.440 Why?
Thrombocythemia, Essential220241070.430 Why?
Translocation, Genetic1201813880.420 Why?
Hematologic Neoplasms3201818950.380 Why?
Mutation82024299320.360 Why?
Tissue and Organ Procurement120189440.340 Why?
Repressor Proteins2202429810.320 Why?
Peripheral Blood Stem Cell Transplantation220172630.240 Why?
Leukemia, Large Granular Lymphocytic12024240.240 Why?
Janus Kinase 2220245420.230 Why?
Hemoglobinuria, Paroxysmal12024950.220 Why?
DNA-Binding Proteins3202495850.220 Why?
Calreticulin120241150.210 Why?
Receptors, Thrombopoietin120241610.210 Why?
Transplantation, Homologous3202048100.200 Why?
Magnolia1201930.170 Why?
Neoplasms, Second Primary2201810560.170 Why?
Hematologic Diseases220214960.170 Why?
Transcription Factors12018121030.160 Why?
Clone Cells1202216600.150 Why?
Myelodysplastic-Myeloproliferative Diseases12018150.150 Why?
Myeloproliferative Disorders120246090.150 Why?
Photopheresis12018350.150 Why?
Gene Frequency1202436150.150 Why?
Leukemia, Promyelocytic, Acute120182510.140 Why?
Japan2201813690.140 Why?
Chimerism120171550.140 Why?
Adolescent102024878100.130 Why?
Germ-Line Mutation1202418410.130 Why?
Proto-Oncogene Proteins c-kit120207270.130 Why?
Iodine120182860.130 Why?
Tretinoin120185190.130 Why?
Survival Rate32018128080.120 Why?
Graft vs Host Disease2201830250.120 Why?
Cyclin-Dependent Kinase Inhibitor p16120186980.120 Why?
Young Adult82024587410.120 Why?
Busulfan120152580.120 Why?
Bone Marrow Cells1202224140.120 Why?
Remission Induction1202023920.120 Why?
Middle Aged1620242203520.110 Why?
Protein Kinase Inhibitors2202156430.110 Why?
Bacteremia120219800.110 Why?
Staining and Labeling1201810890.110 Why?
Alleles1202468980.110 Why?
Waiting Lists120187630.110 Why?
Adult1420242199940.100 Why?
Transplantation Conditioning2201715880.100 Why?
Aged1120241691520.090 Why?
Male1720243597440.090 Why?
Female1820243912700.090 Why?
Disease-Free Survival2201868280.090 Why?
Humans2420247606210.090 Why?
Thrombosis1202430520.090 Why?
HLA Antigens1201513680.080 Why?
Kaplan-Meier Estimate1202065440.080 Why?
DNA Mutational Analysis1201841070.080 Why?
Cyclophosphamide1201522210.080 Why?
Dioxygenases220243350.080 Why?
Anticoagulants1202448970.080 Why?
Recurrence1202184820.080 Why?
Combined Modality Therapy1202085520.080 Why?
Disease Progression32024135020.080 Why?
Esophageal Neoplasms1201816480.070 Why?
Drug Resistance, Neoplasm2201952530.070 Why?
Sequence Deletion2201914930.060 Why?
Length of Stay1201864790.060 Why?
Graft Rejection1201744260.060 Why?
Genetic Variation1201965510.060 Why?
Time Factors42018401650.060 Why?
Treatment Outcome32020650170.060 Why?
Point Mutation2201915940.060 Why?
Patient Readmission1201833230.060 Why?
Anemia, Hemolytic120241630.050 Why?
Disease Models, Animal12022181370.050 Why?
Prognosis22020296580.050 Why?
Aged, 80 and over22024589950.050 Why?
Registries1201884690.050 Why?
Bacillus cereus12021360.050 Why?
Tumor Suppressor Protein p532202429190.050 Why?
GTP Phosphohydrolases120245180.050 Why?
Segmental Duplications, Genomic12019190.040 Why?
Core Binding Factor beta Subunit12020420.040 Why?
DNA, Chloroplast1201950.040 Why?
Retrospective Studies32024803720.040 Why?
Phylogeography12019720.040 Why?
Plant Leaves120191510.040 Why?
Protein-Tyrosine Kinases2201824180.040 Why?
Myosin Heavy Chains120204020.040 Why?
Prebiotics12018410.040 Why?
HL-60 Cells120183630.040 Why?
Proto-Oncogene Proteins c-myb12018790.040 Why?
Founder Effect120181860.040 Why?
Graft vs Leukemia Effect120171210.040 Why?
Philadelphia Chromosome120171170.040 Why?
Spliceosomes120181290.040 Why?
Microsatellite Repeats120197860.040 Why?
Lymphocyte Transfusion120172320.030 Why?
Genetic Predisposition to Disease12018177900.030 Why?
GPI-Linked Proteins120174680.030 Why?
Antilymphocyte Serum120174820.030 Why?
Fusion Proteins, bcr-abl120174310.030 Why?
Ecosystem120194850.030 Why?
Cell Line, Tumor22024169390.030 Why?
Mice12022812080.030 Why?
Neoplasms12024220720.030 Why?
Anemia1202415110.030 Why?
Cell Transformation, Neoplastic1202428280.030 Why?
Tacrolimus120177330.030 Why?
Biological Evolution1201910740.030 Why?
Child22018798060.030 Why?
Prospective Studies42020543030.030 Why?
Chronic Disease2201892870.030 Why?
Neoplasm, Residual1201710070.030 Why?
Drug Resistance1201816170.030 Why?
Phylogeny1201927750.020 Why?
Down-Regulation1201829130.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201745730.020 Why?
Proteomics1202438170.020 Why?
Animals120221679630.020 Why?
Follow-Up Studies22024392610.020 Why?
Leukocytes1201720260.020 Why?
Glucocorticoids1201821450.020 Why?
Membrane Proteins1202478500.020 Why?
Feasibility Studies1201752010.020 Why?
Proto-Oncogene Proteins1201844900.020 Why?
Survival Analysis12018101820.020 Why?
Immunosuppressive Agents1201741660.010 Why?
Epigenesis, Genetic1201837580.010 Why?
Immunohistochemistry12018110710.010 Why?
Clinical Trials as Topic1201980560.010 Why?
Gene Expression Regulation, Neoplastic1201885150.010 Why?
Anti-Bacterial Agents1202174080.010 Why?
Gene Expression Profiling1201894110.010 Why?
Signal Transduction12019233760.010 Why?
Infant12018360600.010 Why?
Child, Preschool12018420630.010 Why?
Antineoplastic Agents12018136300.010 Why?
Risk Factors12018743590.010 Why?
Kawashima's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (147)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.